Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Regenerative medicine holds the potential to revolutionize healthcare, but critical work needs to be done now to ensure these new therapies will be safe, effective, affordable, and widely available to patients who need them.
That is one of the key conclusions of a paper published last week in
Cell & Gene Therapy Insights that outlines the recommendations of an international workshop hosted by
Medicine by Design at the University of Toronto (U of T), in collaboration with
Toronto Health Economics and Technology Assessment Collaborative (THETA) at UHN, and
Loughborough University in the U.K.
“As more regenerative medicine therapies move closer to the clinic, now is the time to engage policy makers, governments, healthcare providers and other stakeholders in these important conversations,” says Dr.Murray Krahn, the paper’s corresponding author and director of THETA.
Read more about the paper.
“Laying this groundwork early will ensure our healthcare system can adopt and implement regenerative medicine therapies efficiently and effectively, and in ways that align with the social values of Canadians,” adds Dr. Krahn, who is also an attending physician at UHN, Senior Scientist at the Toronto General Hospital Research Institute and a professor at the Leslie Dan Faculty of Pharmacy and the Faculty of Medicine at U of T.
Funded by a $114-million grant from the federal government's
Canada First Research Excellence Fund, Medicine by Design brings together more than 130 researchers from across U of T and its affiliated hospitals to advance regenerative medicine discoveries and accelerate them toward impact.